Poor compliance with community-acquired pneumonia antibiotic guidelines in a large Australian private hospital emergency department

Microbial Drug Resistance

Volumn 20, Issue 6, 2014, Pages 561-567

  Robinson, Helen L ^a   Robinson, Philip C ^b   Whitby, Michael ^b  

^a IPSWICH HOSPITAL   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; AZITHROMYCIN; CEFOTAXIME; CEFTRIAXONE; CLARITHROMYCIN; DOXYCYCLINE; GENTAMICIN; MOXIFLOXACIN; PENICILLIN G; ROXITHROMYCIN; ANTIINFECTIVE AGENT;

ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; AUSTRALIA; COMMUNITY ACQUIRED PNEUMONIA; DRUG CHOICE; EMERGENCY WARD; FEMALE; GROUPS BY AGE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRACTICE GUIDELINE; PRIVATE HOSPITAL; PROTOCOL COMPLIANCE; ADOLESCENT; COMMUNITY-ACQUIRED INFECTIONS; DRUG EFFECTS; EMERGENCY HEALTH SERVICE; HOSPITALIZATION; MIDDLE AGED; PNEUMONIA; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; AUSTRALIA; COMMUNITY-ACQUIRED INFECTIONS; DRUG RESISTANCE, MICROBIAL; EMERGENCY SERVICE, HOSPITAL; HOSPITAL MORTALITY; HOSPITALIZATION; HOSPITALS, PRIVATE; HUMANS; MIDDLE AGED; PNEUMONIA; YOUNG ADULT;

EID: 84915805618     PISSN: 10766294     EISSN: 19318448     Source Type: Journal    
DOI: 10.1089/mdr.2014.0064     Document Type: Article

References (38)

1. Antibiotic Expert Group. 2010. Therapeutic Guidelines: Antibiotics, Version 14. Therapeutic Guidelines Limited, Melbourne.
2. Antibiotic Guidelines Sub-Committee; Victorian Drug Usage Advisory Committee. 1992, 1994, 1996. Antibiotics Guidelines/Therapeutic Guidelines Antibiotics, 7, 8 and 9 editions. Therapeutic Guidelines Limited, Victoria, Australia.
3. Duguid, M., and M. Cruickshank. (eds.). 2010. Antibiotic Stewardship in Australian Hospitals. The Australian Commission of Safety and Quality in Healthcare, Sydney, Australia.
4. Australasian College of EmergencyMedicine. 2013. Policy on the Australasian Triage Scale. The Australasian College of Emergency Medicine, West Melbourne, Australia.
5. Battleman, D.S., M. Callahan, and H.T. Thaler. 2002. Rapid antibiotic delivery and appropriate antibiotic selection reduce length of hospital stay of patients with community-acquired pneumonia: link between quality of care and resource utilization. Arch. Intern. Med. 162:682-688.
6. Berman, P., D.B. Hogan, and R.A. Fox. 1987. The atypical presentation of infection in old age. Age Ageing 16:201-207.
7. Buising, K.L., K.A. Thursky, J.F. Black, L. MacGregor, A.C. Street, M.P. Kennedy, et al. 2007. Identifying severe community-acquired pneumonia in the emergency department: a simple clinical prediction tool. Emerg. Med. Australas. 19:418-426.
8. Centre for Healthcare Related Infection Surveillence and Prevention. Initial Antibiotic Management of Community-Acquired Pneumonia in Adults (Version 4.1). Queensland Health, 2010 [cited 2012 March 5th]. Available from: www.health.qld.gov.au/chrisp/resources/cap-fsheet .pdf. (Online.).
9. Charles, P.G., M. Whitby, A.J. Fuller, R. Stirling, A.A. Wright, T.M. Korman, et al. 2008. The etiology of community-acquired pneumonia in Australia: why penicillin plus doxycycline or a macrolide is the most appropriate therapy. Clin. Infect. Dis. 46:1513-1521.
10. Dancer, S.J. 2001. The problem with cephalosporins. J. Antimicrob. Chemother. 48:463-478.
11. Esposito, A.L. 1984. Community-acquired bacteremic pneumococcal pneumonia. Effect of age on manifestations and outcome. Arch. Intern. Med. 144:945-948.
12. Gottlieb, T., and G.R. Nimmo. 2011. Antibiotic resistance is an emerging threat to public health: an urgent call to action at the Antimicrobial Resistance Summit 2011. Med. J. Aust. 194:281-283.
13. Harper, C., and P. Newton. 1989. Clinical aspects of pneumonia in the elderly veteran. J. Am. Geriatr. Soc. 37:867-872.
14. Hill, D.A., T. Herford, and D. Parratt. 1998. Antibiotic usage and methicillin-resistant Staphylococcus aureus: an analysis of causality. J Antimicrob. Chemother. 42:676-677.
15. Houck, P.M., and D.W. Bratzler. 2005. Administration of first hospital antibiotics for community-acquired pneumonia: does timeliness affect outcomes Curr. Opin. Infect. Dis. 18:151-156.
16. Houck, P.M., D.W. Bratzler, W. Nsa, A. Ma, and J.G. Bartlett. 2004. Timing of antibiotic administration and outcomes for Medicare patients hospitalized with community-acquired pneumonia. Arch. Intern. Med. 164:637-644.
17. Ingram, P.R., J.M. Seet, C.A. Budgeon, and R. Murray. 2012. Point-prevalence study of inappropriate antibiotic use at a tertiary Australian hospital. Intern. Med. J. 42: 719-721.
18. Jacobson, K.L., S.H. Cohen, J.F. Inciardi, J.H. King, W.E. Lippert, T. Iglesias, et al. 1995. The relationship between antecedent antibiotic use and resistance to extended-spectrum cephalosporins in group I beta-lactamaseproducing organisms. Clin. Infect. Dis. 21:1107-1113.
19. Jones, R.N. 1998. Important and emerging beta-lactamasemediated resistances in hospital-based pathogens: the Amp C enzymes. Diagn. Microbiol. Infect. Dis. 31:461-466.
20. Kanwar, M., N. Brar, R. Khatib, and M.G. Fakih. 2007. Misdiagnosis of community-acquired pneumonia and inappropriate utilization of antibiotics: side effects of the 4-h antibiotic administration rule. Chest 131:1865-1869.
21. Laxminarayan, R., A. Duse, C. Wattal, A.K. Zaidi, H.F. Wertheim, N. Sumpradit, et al. 2013. Antibiotic resistance-the need for global solutions. Lancet Infect. Dis. 13:1057-1098.
22. Maltezou, H.C., E. Maltezos, A. Antoniadou, G.M. Gourgoulis, P. Katerelos, G. Adamis, et al. 2014. Prescription of antibiotics and knowledge about antibiotic costs among physicians working in tertiary-care hospitals. J. Chemother. [Epub ahead of print]; DOI: http://dx.doi.org/10.1179/1973947813Y.0000000160.
23. Mandell, L.A.,R.G.Wunderink, A. Anzueto, J.G. Bartlett, G.D. Campbell, N.C. Dean, et al. 2007. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin. Infect. Dis. 44 Suppl 2:S27-S72.
24. Maxwell, D.J., K.A. McIntosh, L.K. Pulver, and K.L. Easton. 2005. Empiric management of communityacquired pneumonia in Australian emergency departments. Med. J. Aust. 183:520-524.
25. McIntosh, K.A., D.J. Maxwell, L.K. Pulver, F. Horn, M.B. Robertson, K.I. Kaye, et al. 2011. A quality improvement initiative to improve adherence to national guidelines for empiric management of community-acquired pneumonia in emergency departments. Int. J. Qual. Health Care 23:142-150.
26. Meehan, T.P., M.J. Fine, H.M. Krumholz, J.D. Scinto, D.H. Galusha, J.T. Mockalis, et al. 1997. Quality of care, process, and outcomes in elderly patients with pneumonia. JAMA 278:2080-2084.
27. Monnet, D.L. 1998. Methicillin-resistant Staphylococcus aureus and its relationship to antimicrobial use: possible implications for control. Infect. Control Hosp. Epidemiol. 19:552-559.
28. Pallares, R., M. Pujol, C. Pena, J. Ariza, R. Martin, and F. Gudiol. 1993. Cephalosporins as risk factor for nosocomial Enterococcus faecalis bacteremia. A matched casecontrol study. Arch. Intern. Med. 153:1581-1586.
29. Peacock, J.E., Jr., F.J. Marsik, and R.P. Wenzel. 1980. Methicillin-resistant Staphylococcus aureus: introduction and spread within a hospital. Ann. Intern. Med. 93:526-532.
30. Productivity Commission. 2009. Public and Private Hospitals: Research Report. Canberra. Productivity Commission, Melbourne, Australia.
31. Ruiz, L.A., A. Gomez, C. Jaca, L. Martinez, B. Gomez, and R. Zalacain. 2010. Bacteraemic community-acquired pneumonia due to Gram-negative bacteria: incidence, clinical presentation and factors associated with severity during hospital stay. Infection 38:453-458.
32. Silber, S.H., C. Garrett, R. Singh, A. Sweeney, C. Rosenberg, D. Parachiv, et al. 2003. Early administration of antibiotics does not shorten time to clinical stability in patients with moderate-to-severe community-acquired pneumonia. Chest 124:1798-1804.
33. Skull, S.A., R.M. Andrews, G.B. Byrnes, D.A. Campbell, H.A. Kelly, G.V. Brown, et al. 2009. Hospitalized community-acquired pneumonia in the elderly: an Australian case-cohort study. Epidemiol. Infect. 137:194-202.
34. Thuong, M., F. Shortgen, V. Zazempa, E. Girou, C.J. Soussy, and C. Brun-Buisson. 2000. Appropriate use of restricted antimicrobial agents in hospitals: the importance of empirical therapy and assisted re-evaluation. J. Antimicrob. Chemother. 46:501-508.
35. Tsirgiotis, E, and R. Ruffin. 2000. Community acquired pneumonia. A perspective for general practice. Aust. Fam. Physician 29:639-645.
36. Tunger, O., G. Dinc, B. Ozbakkaloglu, U.C. Atman, and U. Algun. 2000. Evaluation of rational antibiotic use. Int. J. Antimicrob. Agents 15:131-135.
37. World Health Organisation. WHO Global Strategy for Containment of Antibmicrobial Resistance Geneva, 2001. Available from: www.who.int/drugresistance/WHO-Global-Strategy-English.pdf. (Online.) Accessed June 14, 2014.
38. Writing Group for Therapeutic Guidelines: Antibiotics. 1998. Therapeutic Guidelines Antibiotics, 10th edition. Therapeutic Guidelines Limited, Victoria, Australia.